{"id":"https://openalex.org/W2164337291","doi":null,"title":"Analysis of the response and toxicity to gefitinib of non-small cell lung cancer.","display_name":"Analysis of the response and toxicity to gefitinib of non-small cell lung cancer.","publication_year":2005,"publication_date":"2005-01-01","ids":{"openalex":"https://openalex.org/W2164337291","mag":"2164337291","pmid":"https://pubmed.ncbi.nlm.nih.gov/15816608"},"language":"en","primary_location":{"id":"pmid:15816608","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15816608","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://hdl.handle.net/2115/15889","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051036952","display_name":"Jun Sakakibara Konishi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I205349734","display_name":"Hokkaido University","ror":"https://ror.org/02e16g702","country_code":"JP","type":"education","lineage":["https://openalex.org/I205349734"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Jun Konishi","raw_affiliation_strings":["First Department of Medicine, Hokkaido University School of Medicine, Kita-ku, Sapporo 060-8638, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"First Department of Medicine, Hokkaido University School of Medicine, Kita-ku, Sapporo 060-8638, Japan","institution_ids":["https://openalex.org/I205349734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113679162","display_name":"Koichi Yamazaki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Koichi Yamazaki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037474733","display_name":"Ichiro Kinoshita","orcid":"https://orcid.org/0000-0002-6694-8414","observed_orcids":["https://orcid.org/0000-0002-6694-8414"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ichiro Kinoshita","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017693924","display_name":"Hiroshi Isobe","orcid":"https://orcid.org/0000-0002-5711-4629","observed_orcids":["https://orcid.org/0000-0002-5711-4629"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiroshi Isobe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108223685","display_name":"Shigeaki Ogura","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shigeaki Ogura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037657657","display_name":"Satoko Sekine","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Satoko Sekine","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038817476","display_name":"Takashi Ishida","orcid":"https://orcid.org/0000-0002-1060-0777","observed_orcids":["https://orcid.org/0000-0002-1060-0777"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Takashi Ishida","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049890081","display_name":"Riou Takashima","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Riou Takashima","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064222483","display_name":"Megumi Nakadate","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Megumi Nakadate","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008873940","display_name":"Shyu Nishikawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shyu Nishikawa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111501061","display_name":"Takeshi Hattori","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Takeshi Hattori","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062751192","display_name":"Hajime Asahina","orcid":"https://orcid.org/0000-0002-7126-3153","observed_orcids":["https://orcid.org/0000-0002-7126-3153"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hajime Asahina","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103744540","display_name":"Mikado Imura","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mikado Imura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076506991","display_name":"Eiki Kikuchi","orcid":"https://orcid.org/0000-0003-4098-6321","observed_orcids":["https://orcid.org/0000-0003-4098-6321"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eiki Kikuchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022152190","display_name":"Junko Kikuchi","orcid":"https://orcid.org/0000-0002-7839-1334","observed_orcids":["https://orcid.org/0000-0002-7839-1334"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Junko Kikuchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035668565","display_name":"Naofumi Shinagawa","orcid":"https://orcid.org/0000-0002-7904-3702","observed_orcids":["https://orcid.org/0000-0002-7904-3702"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naofumi Shinagawa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047702281","display_name":"Hiroshi Yokouchi","orcid":"https://orcid.org/0000-0001-5964-0051","observed_orcids":["https://orcid.org/0000-0001-5964-0051"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiroshi Yokouchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113948887","display_name":"Mitsuru Munakata","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mitsuru Munakata","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045120486","display_name":"Hirotoshi Dosaka\u2010Akita","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hirotoshi Dosaka-Akita","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5081243390","display_name":"Masaharu Nishimura","orcid":"https://orcid.org/0000-0002-6456-4361","observed_orcids":["https://orcid.org/0000-0002-6456-4361"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masaharu Nishimura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.982,"has_fulltext":true,"cited_by_count":26,"citation_normalized_percentile":{"value":0.91491222,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"25","issue":"1B","first_page":"435","last_page":"41"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":1.0},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.9570000171661377},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.7599999904632568},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9670000076293945},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8930000066757202},{"id":"https://openalex.org/keywords/interstitial-pneumonitis","display_name":"interstitial pneumonitis","score":0.8009999990463257},{"id":"https://openalex.org/keywords/smoking-status","display_name":"smoking status","score":0.6290000081062317},{"id":"https://openalex.org/keywords/adenocarcinoma","display_name":"adenocarcinoma","score":0.8709999918937683},{"id":"https://openalex.org/keywords/performance-status","display_name":"performance status","score":0.7559999823570251},{"id":"https://openalex.org/keywords/gender-differences","display_name":"gender differences","score":0.4259999990463257}],"concepts":[{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.9837108254432678},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.778795063495636},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.7074403762817383},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6854234933853149},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6321515440940857},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.6240594983100891},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.5568735599517822},{"id":"https://openalex.org/C144301174","wikidata":"https://www.wikidata.org/wiki/Q7893852","display_name":"Univariate analysis","level":3,"score":0.5332633256912231},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4609139561653137},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.45068493485450745},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.43862926959991455},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.34771403670310974},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.34097790718078613}],"mesh":[{"descriptor_ui":"D000077156","descriptor_name":"Gefitinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012737","descriptor_name":"Sex Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012907","descriptor_name":"Smoking","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015999","descriptor_name":"Multivariate Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"pmid:15816608","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15816608","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},{"id":"pmh:oai:eprints.lib.hokudai.ac.jp:2115/15889","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2115/15889","pdf_url":"http://hdl.handle.net/2115/15889","source":{"id":"https://openalex.org/S4306400549","display_name":"Hokkaido University Collection of Scholarly and Academic Papers (Hokkaido University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I205349734","host_organization_name":"Hokkaido University","host_organization_lineage":["https://openalex.org/I205349734"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"article (author version)"},{"id":"pmh:oai:irdb.nii.ac.jp:01364:0007140132","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/2115/15889","pdf_url":"https://eprints.lib.hokudai.ac.jp/repo/huscap/all/15889/AR25-1B.pdf","source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Anticancer Research","raw_type":"journal article"},{"id":"mag:2164337291","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15816608","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:eprints.lib.hokudai.ac.jp:2115/15889","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2115/15889","pdf_url":"http://hdl.handle.net/2115/15889","source":{"id":"https://openalex.org/S4306400549","display_name":"Hokkaido University Collection of Scholarly and Academic Papers (Hokkaido University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I205349734","host_organization_name":"Hokkaido University","host_organization_lineage":["https://openalex.org/I205349734"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"article (author version)"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2164337291.pdf","grobid_xml":"https://content.openalex.org/works/W2164337291.grobid-xml"},"referenced_works_count":2,"referenced_works":["https://openalex.org/W1594148294","https://openalex.org/W2504684570"],"related_works":["https://openalex.org/W2589606748","https://openalex.org/W3011839367","https://openalex.org/W2126736840","https://openalex.org/W2223907674","https://openalex.org/W2023635410","https://openalex.org/W3145798447","https://openalex.org/W3016547674","https://openalex.org/W2369059710","https://openalex.org/W2160500377","https://openalex.org/W2263676542"],"abstract_inverted_index":{"BACKGROUND:":[0],"Gefitinib":[1,139],"is":[2],"an":[3],"oral":[4],"agent":[5],"that":[6],"inhibits":[7],"the":[8,33],"tyrosine":[9],"kinase":[10],"of":[11,40],"epidermal":[12],"growth":[13],"factor":[14],"receptor":[15],"(EGFR),":[16],"which":[17],"had":[18],"antitumor":[19],"activity":[20,143],"in":[21,43,64,82,126,144],"patients":[22,44,54,130],"with":[23,45,55,101,136],"previously":[24],"treated":[25],"non-small":[26],"cell":[27],"lung":[28],"cancer":[29],"(NSCLC).":[30],"We":[31],"analyzed":[32],"efficacy,":[34],"toxicity":[35],"and":[36,52,62,87,111,119,148],"overall":[37,92],"survival":[38,93,103],"time":[39,94],"gefitinib":[41,59],"treatment":[42],"NSCLC.":[46],"PATIENTS":[47],"AND":[48],"METHODS:":[49],"One":[50],"hundred":[51],"twenty-two":[53],"NSCLC,":[56],"who":[57],"received":[58],"between":[60],"2002":[61],"2004":[63],"our":[65],"institutes,":[66],"were":[67,122],"evaluated":[68],"retrospectively.":[69],"RESULTS:":[70],"The":[71,77,90],"objective":[72],"response":[73],"rate":[74],"was":[75,95],"24.6%.":[76],"variables":[78,99],"identified":[79],"as":[80],"significant":[81],"univariate":[83],"analysis":[84],"included":[85,104],"gender":[86],"smoking":[88],"habit.":[89],"median":[91],"14.4":[96],"months.":[97],"Significant":[98],"associated":[100,135],"improved":[102],"good":[105,120],"performance":[106],"status":[107,118],"(PS),":[108],"female,":[109],"adenocarcinoma":[110],"never":[112,116,146],"smoked":[113,117],"status,":[114],"while":[115],"PS":[121],"independent":[123],"prognostic":[124],"factors":[125],"multivariate":[127],"analysis.":[128],"Four":[129],"(3.3%)":[131],"developed":[132],"interstitial":[133],"pneumonitis":[134],"gefitinib.":[137],"CONCLUSION:":[138],"showed":[140],"favorable":[141],"anti-tumor":[142],"females,":[145],"smokers":[147],"adenocarcinoma.":[149]},"counts_by_year":[{"year":2023,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}